Do Educational Digital Films Enhance Patient COPD Outcomes?

January 10, 2019 updated by: Aberystwyth University

Do Patients With Chronic Obstructive Pulmonary Disease Engaging With Educational Films in Addition to Pulmonary Rehabilitation Gain Health-related Improvements?

This study aims to assess the efficacy of Pocket Medic to promote self-management and pulmonary rehabilitation adherence in COPD patients.

Study Overview

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) refers to a group of lung conditions characterized by airways inflammation, small airways obstruction and progressive loss of lung function. There are 900,000 people diagnosed with COPD in England and Wales but allowing for under-diagnosis, the true prevalence could be 1.5 million. Sufferers are extensive health care users; where COPD is the second most common cause of emergency hospital admission in the United Kingdom with direct National Health Service costs over £800 million per year. Pulmonary Rehabilitation programs (PRPs) aim to provide education and support for patients whilst improving clinical outcomes, however, attendance to these programs can be low.

This study aims to trial a series of digital films aimed at educating patients about their condition from the comfort of their own home. Approximately 80 patients eligible for PR will be allocated to an experimental condition to receive a series of 10 digital films alongside their standard 7-week PR, solely to receive 10 digital films, or to a control condition in the form of standard PR (no digital films). Outcome measures such as PR attendance, hospital admissions, quality of life (QoL), disease knowledge, psychological need satisfaction and motivation will be measured pre and post. Analysis of this data between the experimental and control conditions pre-post intervention will provide useful information regarding the efficacy of digital film prescriptions as an adjunct to usual PR, or on its own, and the role this may play is encouraging PR attendance.

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Carmarthenshire
      • Carmarthen, Carmarthenshire, United Kingdom, SA31 2AF
        • Glangwilli Hospital
      • Llanelli, Carmarthenshire, United Kingdom, SA14 8QF
        • Prince Phillip Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Eligible for pulmonary rehabilitation in Hywel Dda University Health Board.

Exclusion Criteria:

  • Unwilling or unable to give informed consent
  • life expectancy of less than 6 months
  • unstable cardiovascular disease, dementia, cancers other than non-melanoma skins cancer
  • any condition that precludes patients using laptops or mobile phones (e.g. blind, deaf)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
10 short digital films utilising self-determination theory aiming to increase patient self-management
PR follows National Institute for Clinical Excellence guidelines delivering 14 sessions over 7 weeks utilising a multidisciplinary approach
Active Comparator: Control
PR follows National Institute for Clinical Excellence guidelines delivering 14 sessions over 7 weeks utilising a multidisciplinary approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient engagement
Time Frame: 10 weeks
The level at which patients in the intervention arm watch the digital films
10 weeks
Patient Adherence
Time Frame: 10 weeks
The level at which patients attend pulmonary rehabilitation sessions
10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disease Knowledge
Time Frame: 10 weeks and 6 months
Scores on Bristol COPD Knowledge Questionnaire
10 weeks and 6 months
Service Utilization
Time Frame: Baseline and 6 months
Number of General Practioner visits and hospitalizations
Baseline and 6 months
Psychological self-management
Time Frame: 10 weeks and 6 months
Patient scores on self-determination theory questionnaires modified to be relevant to COPD
10 weeks and 6 months
Understanding COPD self-management
Time Frame: 10 weeks and 6 months
Scores on the Understanding COPD self-management questionnaire
10 weeks and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Liam Knox, Aberystwyth University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2016

Primary Completion (Actual)

July 1, 2018

Study Completion (Actual)

July 1, 2018

Study Registration Dates

First Submitted

August 24, 2017

First Submitted That Met QC Criteria

August 25, 2017

First Posted (Actual)

August 28, 2017

Study Record Updates

Last Update Posted (Actual)

January 11, 2019

Last Update Submitted That Met QC Criteria

January 10, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 10203918b3002e6f1be4a19987

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Pocket Medic

3
Subscribe